

You might not be familiar with the term translational research. But, if you or a loved one is being treated for cancer, you might benefit—without realizing it—from findings that are the result of this type of research. Translational research uses observa...
Read MoreRevised March 13, 2020 For people diagnosed with neuroendocrine tumors (NET), treatment has historically worked to prevent advancement of the disease, but there were no therapies available that actually shrunk these tumors – until now. Some types of t...
Read MoreUpdated November 17, 2020 Here’s a shocking statistic: In the United States, about 20% of people who die from lung cancer every year have never smoked or used any other form of tobacco. “We are seeing a greater percentage of lung cancer patients who h...
Read MoreFox Chase Cancer Center’s Robert G. Uzzo, MD, FACS, received the 2018 SUO Medal from the Society of Urologic Oncology (SUO) for his significant contributions to the field of urologic oncology. This prestigious award is presented to one member of SUO annuall...
Read MoreWith fewer people smoking in the US, why are lung cancer rates among people who have never smoked on the rise? “While it is true that smoking tobacco is the top risk factor for lung cancer, a substantial number of people receive a diagnosis despite having n...
Read MoreThis week the Fox Chase Immersion Science Program (ISP) hosted a day-long symposium where 236 students from 6 area high schools presented data they spent the school year gathering. The research projects all focused on the effects of different dietary chemic...
Read More